Jon Faiz Kayyem - Dec 6, 2021 Form 4 Insider Report for BIODESIX INC (BDSX)

Role
Director
Signature
/s/ Robin H. Cowie as Attorney-in-Fact for Jon Faiz Kayyem
Stock symbol
BDSX
Transactions as of
Dec 6, 2021
Transactions value $
$0
Form type
4
Date filed
12/8/2021, 03:30 PM
Previous filing
Jun 8, 2021
Next filing
May 26, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSX Restricted Stock Units Award $0 +31.6K $0.00 31.6K Dec 6, 2021 Common Stock 31.6K Direct F1, F2
transaction BDSX Stock Options (Right to Buy) Award $0 +50.4K $0.00 50.4K Dec 6, 2021 Common Stock 50.4K $5.93 Direct F3
transaction BDSX Stock Options (Right to Buy) Award $0 +27K $0.00 27K Dec 7, 2021 Common Stock 27K $5.67 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F2 These restricted stock units will vest in full on December 6, 2022, generally subject to the reporting person's continued service on the Issuer's board of directors (the "Board") through the applicable vesting date, and have no expiration date.
F3 This option vests 40% on December 6, 2023, and the remaining 60% in 36 successive, equal monthly installments measured from December 6, 2023, generally subject to the reporting person's continued service on the Board through the applicable vesting date.
F4 This option will vest in full on March 31, 2022, subject to the reporting person's continued service on the Board through the applicable vesting date. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period.